IMRT combined with endocrine therapy demonstrated promising efficacy and was well tolerated in patients with intermediate and advanced prostate cancer.
María Luisa Martínez ChacónCor F. Winkler PrinsJavier Sanz‐LópezEnric FerrerJosep Magrans
Antoni Tarruella RuestesJoaquı́n López-Soriano
Tarruella Ruestes, AntoniLopez-Soriano, Joaquin